Drug discovery

We are a world leader in drug discovery, development and innovation with programs directed to diseases such as COVID-19, malaria, mental health, cardiovascular disease, diabetes, maternal health and others.

Our impact

Our vision is to be an international leader in drug discovery and development with impact in the treatment of major global health burdens.

Collaborators and industry partners

Drug discovery and the optimised use of medicines is complex and multidisciplinary. Collaboration is vital and our collaborators and industrial partners are a critical part of our mission.

Our business development activities

Business development at MIPS encompasses the ideas, strategies, and activities that contribute to improving the way we engage in pre-commercial drug development and interactions with commercial groups.

How does drug discovery work?

MIPS advisory board member Mark Noe from Pfizer explains the drug discovery process.

Our drug discovery platforms

At MIPS we deploy significant research infrastructure and experience to support internal drug discovery programs. This infrastructure is arranged into a series of research platforms that are also available to external partners to help progress their projects. The platforms are part of a broader network of Monash Technology Research Platforms and can be accessed externally via a range of models of interaction from collaboration through to fee-for-service.